A biotechnology company is developing modified immune system cells programmed to sense and respond to cancer cells with targeted therapeutic proteins. . . . → Read More: T-Cells Engineered to Release Anti-Cancer Proteins
|
|||||
|
|
In lab animal tests, an injectable silicon-metal material performs as well as conventional electrodes for electrical nerve stimulation, an emerging therapy for pain. . . . → Read More: Liquid Injectable Electrodes Designed for Nerve Stimulation 
A miniaturized bio-electronic device implanted in a pig can process filtered blood like a real kidney without triggering an immune response or blood clots. . . . → Read More: Artificial Kidney Component Passes Preclinical Test 
A plastic chip device lined with liver cells is shown to better predict drug toxicity in humans than lab animals, including drugs that progressed to failed clinical trials. . . . → Read More: Chip Device More Accurate for Drug Toxicity Than Animals 
A bio-engineering team shows a single experimental gene therapy cocktail can reduce or reverse four age-related diseases in lab mice. . . . → Read More: Gene Therapy Combo Treats Multiple Age-Related Diseases  One comment - (Comments are closed)  New products  biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
An implanted device that senses an overdose of opioid drugs and dispenses an emergency rescue medicine is in development by two university labs. . . . → Read More: Implanted Overdose Rescue Device Being Developed Comments are closed Finance, New products biomedical, engineering, grant, life sciences, medical device, NIH, pharmaceuticals, preclinical, university 
Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain. . . . → Read More: Nanoparticles Designed to Cross Blood-Brain Barrier One comment - (Comments are closed) New products biomedical, biotechnology, engineering, entrepreneurs, Europe, genomics, life sciences, nanotechnology, pharmaceuticals, preclinical, U.K., university 
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, Europe, genomics, licensing, life sciences, pharmaceuticals, preclinical, U.K. 
A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease. . . . → Read More: Dementia Drug Candidate in Preclinical Tests Comments are closed Finance, New products biomedical, biotechnology, grant, life sciences, NIH, pharmaceuticals, preclinical, university 
Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment. . . . → Read More: Nanotech Crispr Delivery in Development Comments are closed Finance, New products biomedical, biotechnology, cancer, engineering, genomics, grant, life sciences, nanotechnology, NIH, pharmaceuticals, preclinical, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||